The role of the proteasome in autoimmunity

Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):325-37. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr144>3.0.co;2-o.

Abstract

Type 1 diabetes is believed to be caused by T cell-mediated autoimmunity, with a prediabetic state characterized by the production of autoantibodies specific for proteins expressed by pancreatic beta cells. The non-obese diabetic (NOD) mouse is a spontaneous model of Type 1 diabetes with a strong genetic component that maps to the major histocompatibility complex (MHC) region of the genome. A specific proteasome defect has now been identified in NOD mouse lymphocytes that results from down-regulation of expression of the proteasome subunit LMP2, which is encoded by a gene in the MHC genomic region. This defect both prevents the proteolytic processing required for the production and activation of the transcription factor nuclear factor-kappaB (NF-kappaB), which plays an important role in immune and inflammatory responses, in addition to increasing the susceptibility of the affected cells to apoptosis induced by tumor necrosis factor-alpha (TNF-alpha). The proteasome dysfunction is both tissue- and developmental stage-specific and likely contributes to disease pathogenesis and tissue targeting.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoantibodies / immunology
  • Autoimmunity
  • Cysteine Endopeptidases / immunology*
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology*
  • Humans
  • Islets of Langerhans / immunology
  • Major Histocompatibility Complex
  • Mice
  • Mice, Inbred NOD
  • Multienzyme Complexes / immunology*
  • Proteasome Endopeptidase Complex
  • T-Lymphocytes / immunology

Substances

  • Autoantibodies
  • Multienzyme Complexes
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex